1. The metabolic landscape of urological cancers: New therapeutic perspectives
   Vera Miranda-Gonçalves et al, 2020, Cancer Letters CrossRef
2. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
   Julieta Afonso et al, 2023, Cancers CrossRef
3. Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
   Aleksandra Semeniuk-Wojtaś et al, 2023, Cancer Immunology, Immunotherapy CrossRef
4. Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors
   Minoru Fujino et al, 2016, Oncology Letters CrossRef
5. Evaluation of grade and invasiveness of bladder urothelial carcinoma using infrared imaging and machine learning
   Monika Kujdowicz et al, 2023, The Analyst CrossRef
6. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
   Mathijs P. Scholtes et al, 2021, Cancers CrossRef
7. Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells
   Alex H. Li et al, 2024, International Journal of Molecular Sciences CrossRef
8. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
   Martine Bocchini et al, 2020, Frontiers in Oncology CrossRef
9. PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking
   Mingyue Tan et al, 2024, Journal of Translational Medicine CrossRef
10. What’s new about the tumor microenvironment of urothelial carcinoma?
    João Queirós Coelho et al, 2024, Clinical and Translational Oncology CrossRef
11. The BRAF V600E Mutation in Papillary Thyroid Carcinoma Is Associated with Glucose Transporter 1 Overexpression
    Florian Grabellus et al, 2012, Thyroid CrossRef
12. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer
    Yi-Fang Yang et al, 2021, International Journal of Molecular Sciences CrossRef
13. Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis
    Oleksandr Stakhovskyi et al, 2022, Cells CrossRef
14. Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors
    Shota Amano et al, 2023, World Journal of Surgical Oncology CrossRef
15. Urothelial Signaling
    Lori Birder et al, 2013, Physiological Reviews CrossRef
16. Utility of early dynamic and delayed post-diuretic18F-FDG PET/CT SUVmaxin predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study
    Abhishek Sharma et al, 2017, The British Journal of Radiology CrossRef
17. The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism
    Vanessa R. Conde et al, 2015, Experimental Cell Research CrossRef
18. An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions
    C Xu et al, 2017, Cancer Gene Therapy CrossRef
19. High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
    Daejin Kim et al, 2019, Journal of Diabetes Research CrossRef
20. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
    Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
21. Glucose transporters as markers of diagnosis and prognosis in cancer diseases
    Leszek Szablewski, 2022, Oncology Reviews CrossRef
22. Glucose transporter 1 expression in bladder carcinoma and its association with human epidermal growth factor receptor-2 and Ki-67
    Renu Thambi et al, 2019, Saudi Journal for Health Sciences CrossRef